Freshwater Freshwater is sometimes adequate to kill the sea lice and as salmon eventually swim in fresh water, they are not harmed.
Drugs and vaccines The range of therapeutants for farmed fish was limited, often due to regulatory processing limitations. All drugs used have been assessed for environmental impact and risks. The parasiticides are classified into bath and in-feed treatments as follows:
Bath treatments There are both advantages and disadvantages to using bath treatments. Bath treatments are more difficult and need more manpower to administer, requiring skirts or tarpaulins to be placed around the cages to contain the drug. Prevention of reinfection is a challenge since it is practically impossible to treat an entire bay in a short time period. Since the volume of water is imprecise, the required concentration is not guaranteed. Crowding of fish to reduce the volume of drug can also stress the fish. Recent use of well-boats containing the drugs has reduced both the concentration and environmental concerns, although transferring fish to the well boat and back to the cage can be stressful. The major advantage to bath treatments is that all the fish will be treated equally, in contrast to in-feed treatments where amount of drug ingested can vary due to a number of reasons.
Organophosphates Organophosphates are
acetylcholinesterase inhibitors and cause excitatory paralysis leading to death of sea lice when given as a bath treatment.
Dichlorvos was used for many years in Europe and later replaced by
azamethiphos, the active ingredient in Salmosan, which is safer for operators to handle. Azamethiphos is water-soluble and broken down relatively quickly in the environment. Resistance to organophosphates began to develop in Norway in the mid 1990s, apparently due to acetylcholinesterases being altered due to mutation. Use has declined considerably with the introduction of SLICE,
emamectin benzoate.
Pyrethroids Pyrethroids are direct stimulators of sodium channels in neuronal cells, inducing rapid depolarization and spastic paralysis leading to death. The effect is specific to the parasite since the drugs used are only slowly absorbed by the host and rapidly metabolized once absorbed.
Cypermethrin (Excis, Betamax) and
deltamethrin (Alphamax) are the two pyrethroids commonly used to control sea lice. Resistance to pyrethroids has been reported in Norway and appears to be due to a mutation leading to a structural change in the sodium channel which prevents pyrethroids from activating the channel. Use of deltamethrin has been increasing as an alternate treatment with the rise in resistance observed with emamectin benzoate.
Topical disinfectants Bathing fish with
hydrogen peroxide (350–500 mg/L for 20 min) will remove mobile sea lice from fish. It is environmentally friendly since H2O2 dissociates to water and oxygen, but can be toxic to fish, depending on water temperature, as well as to operators. It appears to knock the sea lice off the fish, leaving them capable of reattaching to other fish and reinitiating an infection.
In-feed treatments In-feed treatments are easier to administer and pose less environmental risk than bath treatments. Feed is usually coated with the drug and drug distribution to the parasite is dependent on the
pharmacokinetics of the drug getting in sufficient quantity to the parasite. The drugs have high selective toxicity for the parasite, are quite lipid-soluble so that there is sufficient drug to act for approximately 2 months, and any unmetabolized drug is excreted so slowly that there are little to no environmental concerns.
Avermectins Avermectins belong to the family of macrocyclic lactones and are the major drugs used as in-feed treatments to kill sea lice. The first avermectin used was
ivermectin at doses close to the therapeutic level and was not submitted for legal approval for use on fish by its manufacturer. Ivermectin was toxic to some fish, causing sedation and
central nervous system depression due to the drug's ability to cross the
blood–brain barrier. Emamectin benzoate, which is the active agent in the formulation SLICE, has been used since 1999 and has a greater safety margin on fish. It is administered at 50 μg/kg/day for 7 days and is effective for two months, killing both chalimus and mobile stages.
Withdrawal times vary with jurisdiction from 68 days in Canada to 175 degree days in Norway. Avermectins act by opening glutamate-gated chloride channels in arthropod neuromuscular tissues, causing hyperpolarization and flaccid paralysis leading to death. Resistance has been noted in
Chalimus rogercresseyi in Chile and
L. salmonis on North Atlantic fish farms. The resistance is likely due to prolonged use of the drug leading to up-regulation of P-glycoprotein, similar to what has been seen in nematode resistance to macrocyclic lactones.
Growth regulators Teflubenzuron, the active agent in the formulation Calicide, is a
chitin synthesis inhibitor and prevents moulting. It thus prevents further development of larval stages of sea lice, but has no effect on adults. It has been used only sparingly in sea lice control, largely due to concerns that it may affect the moult cycle of non-target
crustaceans, although this has not been shown at the concentrations recommended.
Optical methods A more recent advance in the delousing strategy is to use pulsed lasers operating at the wavelength of 550 nm to delouse. ==See also==